243 results on '"Klautke, G."'
Search Results
2. F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial
3. Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers
4. 680P HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany
5. 873P Nivolumab (NIVO) in the first-line (1L) or second-line (2L) and later (2L+) settings in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from the German non-interventional study (NIS), HANNA
6. 924P HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
7. OC-0293 TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial
8. Radiosensitizing effect of epothilone B on human epithelial cancer cells
9. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment
10. Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy
11. HANNA : Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
12. HANNA: Real-World Daten (RWD) der Behandlung mit Nivolumab (NIVO) bei Patienten mit rezidivierten oder metastasierten (R/M) Plattenepithelkarzinomen des Kopf-Hals-Bereichs (SCCHN) in Deutschland
13. First-line therapy of advanced head and neck cancer with double checkpoint blockade and radioimmunotherapy - first results.
14. HANNA: Real-world outcomes of patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) treated with nivolumab (NIVO) in Germany
15. Erstlinientherapie fortgeschrittener Kopf-Hals-Karzinome mit Doppel-Checkpoint-Blockade und Radioimmuntherapie - erste Ergebnisse.
16. 927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study
17. 944TiP Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
18. Current status and developments of German curriculum-based residency training programmes in radiation oncology
19. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme
20. Minimally invasive and local treatment for mucosal early gastric cancer
21. DEGRO 2004: 10. Jahreskongress der Deutschen Gesellschaft für Radioonkologie
22. Gesichtsödeme bei einem 61-jährigen Patienten
23. First-line treatment of locally advanced HNSCC with double checkpoint inhibition and radiotherapy based on CD8+ T cell infiltration.
24. Erstlinientherapie fortgeschrittener Kopf-Hals-Karzinome mit Doppel-Checkpoint-Blockade und Radiotherapie in Abhängigkeit der CD8+-T-Zellinfiltration.
25. Neoadjuvante Kurzzeitbestrahlung mit anschließender Chemotherapie oder simultane Radiochemotherapie bei lokal nicht sicher kurativ resektablen Rektumkarzinomen
26. Irinotecan in Radiation Oncology
27. Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)
28. Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12
29. OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial
30. Keine Verbesserung der Behandlungsergebnisse von Operation und postoperativer Strahlentherapie durch eine neoadjuvante Chemotherapie mit TPF bei lokal fortgeschrittenen, primär resektablen Plattenepithelkarzinomen der Mundhöhle
31. Lokale Kontrolle bei T3-Rektumkarzinomen: Kurzzeitbestrahlung versus Radiochemotherapie
32. Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases
33. Betablocker versus Diuretika in der antihypertensiven Therapie: Beeinflussung des Lipid- und Glukosestoffwechsels
34. 1124P - Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial)
35. O-011 - Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12
36. Herstellung, Charakterisierung und Anwendung komplexbildender Austauscher mit Kronenverbindungen oder Kryptanden als Ankergruppen
37. Vorgetäuschte Hyponatriämie bei malignen Paraproteinämien
38. Intensivierte neoadjuvante Radiochemotherapie beim Rektumkarzinom erhöht die Chirurgische Komplikationsrate
39. S3-Leitlinie 'Magenkarzinom' – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs
40. Neoadjuvante Radiochemotherapie bei Patienten mit Rektumkarzinom – Auswirkungen auf die postoperative Stuhlkontinenz im Langzeitverlauf
41. Brachytherapy with Iodine 125 (Gliasite™) in recurrent malignant gliomas – results of a prospective ongoing trial
42. Qualitätskontrolle der multimodalen Therapie des Rektumkarzinoms - Indikation - Durchführung - Komplikationen; Teil 1
43. Vergleich von vier verschiedenen Schemata zur intensivierten neoadjuvanten Radiochemotherapie (RCT) beim lokal fortgeschrittenen Rektumkarzinom (LARC)
44. Is there a role for radiotherapy in the treatment of adenoid cystic carcinoma?
45. Verschlechtert die neoadjuvante Radiochemotherapie beim Rektumkarzinom die Funktion des anorektalen Schließmuskelapparates?
46. weniger Fernmetastasen unter erweiterter Chemotherapie
47. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
48. PD-0455: Investigating a correlation between chemoradiotherapy schedule and survival in limited disease SCLC
49. Der Einfluss der neoadjuvanten Radiochemotherapie auf die postoperative Funktion des analen Sphinkters bei Patienten mit Rektumkarzinom
50. Lokale Kontrolle bei T3-Rektumkarzinomen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.